Cumulative patient burden reduction from negotiated drugs
Cumulative out-of-pocket healthcare expense savings achieved by patients through price-negotiated reimbursement drugs.
Unit billion CNY Industry Pharmaceuticals
The chart
The figure
One published observation so far. A chart follows as soon as a second period is published.
Cumulative patient burden reduction from negotiated drugs
China, as of 31 Oct 2024
Every record
All records
1 record · 1 region · 2018–2024
| Period | Value | Source | Type |
|---|---|---|---|
| China 1 record | |||
| as of 31 Oct 2024 | 880 billion CNY | NHSA · 28 Nov 2024 | actual |
Primary documents
Sources
1 document. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| 国家医疗保障局 医保动态 国家医保局 人力资源社会保障部印发2024年版国家医保药品目录 | NHSA | 28 Nov 2024 | 1 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Cumulative patient burden reduction from negotiated drugs. Retrieved from https://statorigin.org/indicators/cumulative-patient-burden-reduction-from-negotiated-drugs